p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma

Abstract

BackgroundLong intergenic noncoding RNA p21 (lincRNA-p21) is considered a target of wild-type p53, but little is known about its regulation by mutant p53 and its functions during the progression of head and neck squamous cell carcinoma (HNSCC).MethodsRNAscope was used to detect the expression and distribution of lincRNA-p21. Chromatin immunoprecipitation and electrophoretic mobility shift assays were performed to analyze the transcriptional regulation of lincRNA-p21 in HNSCC cells. The biological functions of lincRNA-p21 were investigated in vitro and in vivo. RNA immunoprecipitation and pull-down assays were used to detect the direct binding of lincRNA-p21.ResultsLower lincRNA-p21 expression was observed in HNSCC tissues and indicated worse prognosis. Both wild and mutant type p53 transcriptionally regulated lincRNA-p21, but nuclear transcription factor Y subunit alpha (NF-YA) was essential for mutant p53 in the regulation of lincRNA-p21. Ectopic expression of lincRNA-p21 significantly inhibited cell proliferation capacity in vitro and in vivo and vice versa. Moreover, the overexpression of lincRNA-p21 induced G1 arrest and apoptosis. Knockdown NF-YA expression reversed tumor suppressor activation of lincRNA-p21 in mutant p53 cells, not wild-type p53 cells. A negative correlation was observed between lincRNA-p21 and the phosphorylation of signal transducer and activator of transcription 3 (p-STAT3) in HNSCC tissues. High lincRNA-p21 expression inhibited Janus kinase 2 (JAK2)/STAT3 signal activation and vice versa. Further, we observed direct binding to STAT3 by lincRNA-p21 in HNSCC cells, which suppressed STAT3-induced oncogenic potential.ConclusionsOur results revealed the transcriptional regulation of lincRNA-p21 by the mutant p53/NF-YA complex in HNSCC. LincRNA-p21 acted as a tumor suppressor in HNSCC progression, which was attributed to direct binding to STAT3 and blocking of JAK2/STAT3 signaling.Electronic supplementary materialThe online version of this article (10.1186/s12943-019-0993-3) contains supplementary material, which is available to authorized users.

<p>LncRNA ASB16-AS1 Promotes Growth And Invasion Of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis And Activating Wnt/β-Catenin Pathway</p>

“…10 LincRNA-p21 aberrant downregulation in squamous cell cancer leads to tumor aggravation via STAT3 pathway. 11 Obviously, lncRNAs play critical roles in cancer. And it is important to determine how lncRNA correlates with tumorigenesis.…”

Up-regulated Linc00472 suppresses development of lung cancer cell via inhibition of MiR-196b-5p

“…The development and progression of some human malignancies, especially lung cancer have increasingly been attributed to the dysregulation of lncRNAs [21]. According to a study by Jin S et al [22], downregulation of lincRNA-p21 was observed in head and neck squamous cell carcinoma and indicated poor prognosis. Feng, J et al [23] reported that lncRNA 00504 was up-regulated in colon cancer cell lines and specimens.…”

The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma

“…Cell Counting Kit-8 (CCK-8; Dojindo), 5-ethynyl-2′-deoxyuridine (EdU) (Cell-Light EdU In Vitro Kit, RiboBio), and transwell assays were performed according to our previous study. 16…”